136 related articles for article (PubMed ID: 10629008)
1. Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence.
Braga PC; Sasso MD; Sala MT
J Antimicrob Chemother; 2000 Jan; 45(1):15-25. PubMed ID: 10629008
[TBL] [Abstract][Full Text] [Related]
2. Gemifloxacin: effects of sub-inhibitory concentrations on various factors affecting bacterial virulence.
Dal Sasso M; Culici M; Bovio C; Braga PC
Int J Antimicrob Agents; 2003 Apr; 21(4):325-33. PubMed ID: 12672578
[TBL] [Abstract][Full Text] [Related]
3. Interference of sub-inhibitory concentrations of gatifloxacin on various determinants of bacterial virulence.
Dal Sasso M; Bovio C; Culici M; Braga PC
J Chemother; 2002 Oct; 14(5):473-82. PubMed ID: 12462427
[TBL] [Abstract][Full Text] [Related]
4. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
Braga PC; Dal Sasso M; Mancini L; Sala MT
Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
[TBL] [Abstract][Full Text] [Related]
5. Cefodizime: effects of sub-inhibitory concentrations on adhesiveness and bacterial morphology of Staphylococcus aureus and Escherichia coli: comparison with cefotaxime and ceftriaxone.
Braga PC; Dal Sasso M; Maci S
J Antimicrob Chemother; 1997 Jan; 39(1):79-84. PubMed ID: 9044031
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic effects of subinhibitory concentrations of rufloxacin on bacterial virulence factors.
Braga PC; Sala MT; Dal Sasso M
Antimicrob Agents Chemother; 1999 May; 43(5):1013-9. PubMed ID: 10223908
[TBL] [Abstract][Full Text] [Related]
7. Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
Muratsugu M; Miyake Y; Ishida N; Hyodo A; Terayama K
Biol Pharm Bull; 1995 Sep; 18(9):1259-63. PubMed ID: 8845818
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
Nomura S; Nagayama A
Chemotherapy; 1995; 41(4):267-75. PubMed ID: 7555207
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
Nomura S; Nagayama A
Chemotherapy; 1995; 41(3):178-86. PubMed ID: 7656663
[TBL] [Abstract][Full Text] [Related]
10. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
Labro MT; el Benna J
J Antimicrob Chemother; 1990 Nov; 26 Suppl C():49-57. PubMed ID: 2127416
[TBL] [Abstract][Full Text] [Related]
12. [Effect of sub-inhibitory concentrations of cefixime on the morphology, hemagglutination and adhesiveness of urinary strains of Escherichia coli].
Desnottes JF; Diallo N; Loubeyre C
Presse Med; 1989 Oct; 18(32):1572-5. PubMed ID: 2530535
[TBL] [Abstract][Full Text] [Related]
13. Sub-minimum inhibitory concentrations of ceftibuten reduce adherence of Escherichia coli to human cells and induces formation of long filaments.
Braga PC; Piatti G
Microbiol Immunol; 1993; 37(3):175-9. PubMed ID: 8321147
[TBL] [Abstract][Full Text] [Related]
14. Electrophoretic mobility of cefodizime-treated Staphylococcus aureus and chemiluminescence of human polymorphonuclear leucocytes.
Muratsugu M; Tomonaga M; Miyake Y; Terayama K; Ishida N
J Antimicrob Chemother; 1991 Dec; 28(6):887-96. PubMed ID: 1816185
[TBL] [Abstract][Full Text] [Related]
15. Binding of complement C3 to Klebsiella pneumoniae treated with sub-MIC cefodizime and chemiluminescence response of human polymorphonuclear leukocytes.
Nomura S; Kuroiwa A; Murata K; Nagayama A
Chemotherapy; 1997; 43(2):132-6. PubMed ID: 9084922
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus and Escherichia coli adhesion to human cells is reduced by sub-MICs of gemifloxacin.
Braga PC; Dal SM; Woodnutt G
J Chemother; 2002 Feb; 14(1):41-6. PubMed ID: 11892898
[TBL] [Abstract][Full Text] [Related]
17. Immunological evaluation of cefodizime: a unique molecule among cephalosporins.
Labro MT
Infection; 1992; 20 Suppl 1():S45-7. PubMed ID: 1526677
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy.
Nicoletti G; Blandino G; Cocuzza G; Dainelli B; Maida A; Debbia E; Schito G
Chemotherapy; 1996; 42(2):100-6. PubMed ID: 8697884
[TBL] [Abstract][Full Text] [Related]
19. Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato.
Murgia R; Marchetti F; Cinco M
Antimicrob Agents Chemother; 1999 Dec; 43(12):3030-2. PubMed ID: 10582905
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of a new 3d-generation cephalosporin, cefodizime, on hospital bacteria].
Soussy CJ; Otterbein G; Le Van Thoi J; Duval J; Chanal M; Cluzel M; Sirot D
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):561-6. PubMed ID: 3534743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]